Livio Trentin

67PUBLICATIONS
315CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Characterisation of biological macromoleculesChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (67)

|Aug 13, 2026
Gene Expression, Non-Coding RNA, and Circular RNA Alterations in Patients with T-Prolymphocytic Leukemia.

|Mar 28, 2026
Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.

Stefano Molica, Potito Rosario Scalzulli, Lydia Scarfò

|Jan 07, 2026
Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort.

Enrica Antonia Martino, Annalisa Pitino, Ernesto Vigna

|Sep 29, 2025
Selective inhibition of mitochondrial Kv1.3 prevents and alleviates multiple sclerosis in vivo.

Beatrice Angi, Tatiana Varanita, Marco Puthenparampil

|Sep 19, 2025
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.

Andrea Visentin, Enrico Gaffo, Moritz Fürstenau

|Jul 30, 2025
Serum soluble interleukin-2 receptor levels in hairy cell leukaemia as a marker of tumour burden with prognostic value and as a tool for disease monitoring.

Francesco Angotzi, Alessandro Cellini, Nicolò Danesin

Pageof 12

Frequent Collaborators

32 joint publications

Andrea Visentin

12 joint publications

Luca Laurenti

11 joint publications

Massimo Gentile

10 joint publications

Federica Frezzato